SCHEDULE 13D/A: Stonehill Capital Management Boosts Veradigm Stake to 19.6% and Secures Board Seat

Sentiment:

Schedule 13D Amendment 19 March 2025 1:42 AM

Stonehill Capital Management LLC and its affiliates have significantly increased their beneficial ownership in Veradigm Inc. to 19.6% and appointed a Stonehill partner, Jonathan Sacks, to the company's Board of Directors.

Summary

Stonehill Capital Management LLC, along with its affiliated entities and individuals, now beneficially owns a total of 21,141,983 shares of Veradigm Inc. Common Stock, which represents 19.6% of the outstanding class.
Jonathan Sacks, a partner at Stonehill, was appointed to Veradigm's Board of Directors, effective March 19, 2025, with his term ending at the next annual meeting of stockholders.
In connection with Mr. Sacks' appointment, Stonehill and Mr. Sacks entered into a Confidentiality Agreement with Veradigm, under which the Issuer agreed to include Mr. Sacks on its slate of nominees for the next annual meeting, subject to the Board's fiduciary duties.
The existing Stockholder Rights Agreement, previously amended on February 26, 2024, May 10, 2024, and February 13, 2025, was further amended on March 18, 2025, to designate the Reporting Persons (Stonehill entities and individuals) as 'Exempt Persons' under specific conditions.
The 'Exempt Person' status will remain until Stonehill's beneficial ownership falls below 20% (with certain exceptions) or if Mr. Sacks ceases to serve on the Board/be a Stonehill affiliate AND Stonehill fails to qualify as a 'Passive Investor'.
Veradigm also entered into a Registration Rights Agreement with Stonehill on March 18, 2025, granting Stonehill customary registration rights, including shelf, demand, and piggyback rights, for its Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a positive development for Stonehill Capital Management, securing a significant stake and board representation. For Veradigm, it indicates increased institutional oversight and potential strategic shifts, which can be viewed positively by some investors seeking change, but it's not a direct financial performance update.

Positives

Increased institutional investor involvement and oversight through Stonehill's significant stake and board representation may lead to enhanced corporate governance.
The appointment of a Stonehill partner to the board could bring new strategic insights and perspectives to Veradigm's operations.
The Registration Rights Agreement provides Stonehill with greater liquidity options for its substantial shareholding in Veradigm.

Risks

The 'Exempt Person' status granted to Stonehill under the Rights Agreement is conditional and could be revoked if Stonehill's beneficial ownership exceeds 20% (subject to exceptions) or if Mr. Sacks ceases his board role/Stonehill fails to qualify as a 'Passive Investor', potentially impacting Stonehill's ability to acquire more shares without triggering the rights plan.

Future Outlook

The Issuer has agreed to include Jonathan Sacks on its slate of nominees for the next annual meeting of stockholders for the purposes of electing directors, unless the Board determines it would be inconsistent with its fiduciary duties.

Industry Context

This filing indicates increased activist investor involvement in Veradigm Inc., a company operating in the healthcare IT sector. Such significant stakes and board representation by investment firms like Stonehill Capital Management often signal a desire for strategic changes, operational improvements, or a potential M&A event within the industry.

Comparison to Industry Standards

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Board Member	NA	Jonathan Sacks	March 19, 2025	Appointment by the Issuer's board of directors in connection with Stonehill Capital Management's significant beneficial ownership.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Amendment to Stockholder Rights Agreement	The Rights Agreement was amended to designate Stonehill Capital Management and its affiliates as 'Exempt Persons' under certain conditions, primarily related to their ownership remaining below 20% and Mr. Sacks' board tenure/Stonehill's 'Passive Investor' status.	March 18, 2025	This amendment provides Stonehill with certain protections under the rights plan, allowing them to maintain their significant stake without triggering punitive measures, while also setting conditions for this exemption.
Confidentiality Agreement	Veradigm entered into a Confidentiality Agreement with Stonehill and Jonathan Sacks, which includes a commitment to nominate Mr. Sacks for election at the next annual meeting, subject to fiduciary duties.	March 18, 2025	Formalizes the relationship and commitment regarding board representation, ensuring Stonehill's influence in corporate governance.
Registration Rights Agreement	Veradigm granted Stonehill customary registration rights (shelf, demand, piggyback) for its Common Stock.	March 18, 2025	Provides Stonehill with flexibility and liquidity options for its substantial shareholding, facilitating potential future sales or distributions.

Stakeholder Impact

Shareholders: Increased influence from a significant institutional investor (Stonehill Capital Management) and a new board member, potentially leading to strategic shifts or enhanced oversight.
Management: Will need to collaborate with the new board member and potentially align with Stonehill's strategic objectives.

Next Steps

Veradigm's next annual meeting of stockholders, where Jonathan Sacks is expected to be nominated for election to the Board.

Key Dates

Date	Description
02/26/2024	Original date of the Stockholder Rights Agreement.
05/10/2024	First amendment date of the Stockholder Rights Agreement.
02/13/2025	Second amendment date of the Stockholder Rights Agreement.
03/18/2025	Date of event requiring filing of this statement; date of Confidentiality Agreement, amendment to Rights Agreement, and Registration Rights Agreement.
03/19/2025	Effective date of Jonathan Sacks' appointment to the Board of Directors.

Recommendation

hold

Keywords

Veradigm Inc., Stonehill Capital Management, Schedule 13D, Beneficial Ownership, Board Appointment, Corporate Governance, Shareholder Rights Agreement, Registration Rights, Healthcare IT, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.